Newamsterdam Pharma Stock Investor Sentiment
| NAMS Stock | 19.85 0.95 4.57% |
Slightly above 59% of NewAmsterdam Pharma's investor base is looking to short. The analysis of the overall investor sentiment regarding NewAmsterdam Pharma suggests that many traders are alarmed. NewAmsterdam Pharma's investing sentiment can be driven by a variety of factors including economic data, NewAmsterdam Pharma's earnings reports, geopolitical events, and overall market trends.
Panic Vs Confidence
41
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use NewAmsterdam Pharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward NewAmsterdam Pharma.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
NewAmsterdam Historical Sentiment
Although NewAmsterdam Pharma's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding NewAmsterdam, such as negative comments on social media and news outlets, may cause fear in the market and push NewAmsterdam Pharma's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of NewAmsterdam.
NewAmsterdam |
NewAmsterdam Pharma Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards NewAmsterdam Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about NewAmsterdam Pharma that are available to investors today. That information is available publicly through NewAmsterdam media outlets and privately through word of mouth or via NewAmsterdam internal channels. However, regardless of the origin, that massive amount of NewAmsterdam data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NewAmsterdam Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NewAmsterdam Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NewAmsterdam Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NewAmsterdam Pharma alpha.
NewAmsterdam Pharma Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 09/06/2024 |
2 | Acquisition by Louise Kooij of 45000 shares of NewAmsterdam Pharma subject to Rule 16b-3 | 09/27/2024 |
3 | NewAmsterdam Pharma CAO Louise Frederika Kooij Sells 45,000 Shares | 10/03/2024 |
4 | Disposition of 15000 shares by Davidson Michael H. of NewAmsterdam Pharma at 11.5 subject to Rule 16b-3 | 10/09/2024 |
5 | NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November | 10/28/2024 |
6 | NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results | 11/06/2024 |
7 | NewAmsterdams SWOT analysis obicetrapibs potential lifts stock outlook | 11/12/2024 |
8 | Disposition of 9832 shares by Forgrowth Nap B.v. of NewAmsterdam Pharma at 25.0057 subject to Rule 16b-3 | 11/14/2024 |
9 | Disposition of 33273 shares by Forgrowth Nap B.v. of NewAmsterdam Pharma at 25.0786 subject to Rule 16b-3 | 11/18/2024 |
10 | NewAmsterdam Pharma stock holds Overweight rating with catalysts ahead in Ph3 topline readouts | 11/19/2024 |
11 | Needham Company LLC Reiterates Buy Rating for NewAmsterdam Pharma - MarketBeat | 11/21/2024 |
12 | NewAmsterdam Pharma Trading Down 2.7 percent Heres What Happened | 11/29/2024 |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.